Stuart A Arbuckle Insider Trading $VRTX VERTEX PHARMACEUTICALS INC / MA

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Stuart A Arbuckle.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Stuart A Arbuckle. Stuart A Arbuckle is Director in IMMUNOGEN INC ($IMGN) and EVP, Chief Commercial Officer in VERTEX PHARMACEUTICALS INC / MA ($VRTX) and EVP\Chief Commercial Officer in VERTEX PHARMACEUTICALS INC / MA ($VRTX) and Director in Cerulean Pharma Inc. ($CERU) and Director in RHYTHM PHARMACEUTICALS, INC. ($RYTM).

Stuart A Arbuckle in VERTEX PHARMACEUTICALS INC / MA

Trading Symbol: VRTX
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Stuart A Arbuckle: EVP, Chief Commercial Officer, EVP\Chief Commercial Officer
Holdings: 44,737 shares
Current Value: $3,884,961
Latest Transaction: Feb 26 2021
$VRTX Market Capitalization: $21.78B
$VRTX Previous Close: $86.84

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Stuart A Arbuckle in VERTEX PHARMACEUTICALS INC / MA

Sentiment: All, DARE, IMGN, RYTM, VRTX

Page:   < prev 1 2 3 next >

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Feb 08 2019VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...Option ExerciseA187.5325,0264,693,12625,026
Feb 08 2019VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...GrantA0.009,799071,93762.1 K to 71.9 K (+15.77 %)
Feb 08 2019VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...GrantA0.008,438062,13853.7 K to 62.1 K (+15.71 %)
Feb 08 2019VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...GrantA0.0017,298053,70036.4 K to 53.7 K (+47.52 %)
Feb 06 2019VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...Option ExerciseM86.521,554134,45212,426
Feb 06 2019VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...Option ExerciseM91.052,155196,2138,621
Feb 06 2019VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...Option ExerciseM109.144,250463,8450
Feb 06 2019VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...SellS188.0730056,42136,40236.7 K to 36.4 K (-0.82 %)
Feb 06 2019VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...SellS186.844,044755,58136,70240.7 K to 36.7 K (-9.92 %)
Feb 06 2019VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...SellS186.1012,5652,338,34740,74653.3 K to 40.7 K (-23.57 %)
Feb 06 2019VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...SellS184.811,400258,73453,31154.7 K to 53.3 K (-2.56 %)
Feb 06 2019VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...BuyM86.521,554134,45254,71153.2 K to 54.7 K (+2.92 %)
Feb 06 2019VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...BuyM91.052,155196,21353,15751 K to 53.2 K (+4.23 %)
Feb 06 2019VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...BuyM109.414,250464,99351,00246.8 K to 51 K (+9.09 %)
Feb 06 2019VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...Option ExerciseM86.521,554134,45212,426
Feb 06 2019VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...Option ExerciseM91.052,155196,2138,621
Feb 06 2019VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...Option ExerciseM109.144,250463,8450
Feb 06 2019VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...SellS188.0730056,42136,40236.7 K to 36.4 K (-0.82 %)
Feb 06 2019VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...SellS186.844,044755,58136,70240.7 K to 36.7 K (-9.92 %)
Feb 06 2019VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...SellS186.1012,5652,338,34740,74653.3 K to 40.7 K (-23.57 %)
Feb 06 2019VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...SellS184.811,400258,73453,31154.7 K to 53.3 K (-2.56 %)
Feb 06 2019VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...BuyM86.521,554134,45254,71153.2 K to 54.7 K (+2.92 %)
Feb 06 2019VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...BuyM91.052,155196,21353,15751 K to 53.2 K (+4.23 %)
Feb 06 2019VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...BuyM109.414,250464,99351,00246.8 K to 51 K (+9.09 %)
Jan 24 2019VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...Option ExerciseM131.892,125280,2664,250
Jan 24 2019VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...SellS193.482,125411,14546,75248.9 K to 46.8 K (-4.35 %)
Jan 24 2019VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...BuyM131.892,125280,26648,87746.8 K to 48.9 K (+4.55 %)
Nov 19 2018VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...SellS163.75294,74946,75246.8 K to 46.8 K (-0.06 %)
Nov 08 2018VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...Option ExerciseM131.892,125280,2666,375
Nov 08 2018VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...SellS179.002,125380,37546,75248.9 K to 46.8 K (-4.35 %)
Nov 08 2018VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...BuyM131.892,125280,26648,87746.8 K to 48.9 K (+4.55 %)
Nov 06 2018VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...Option ExerciseM86.521,553134,36613,980
Nov 06 2018VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...Option ExerciseM109.144,250463,8454,250
Nov 06 2018VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...SellS172.081,553267,24046,75248.3 K to 46.8 K (-3.21 %)
Nov 06 2018VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...BuyM86.521,553134,36648,30546.8 K to 48.3 K (+3.32 %)
Nov 06 2018VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...SellS172.084,250731,34046,75251 K to 46.8 K (-8.33 %)
Nov 06 2018VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...BuyM109.144,250463,84551,00246.8 K to 51 K (+9.09 %)
Nov 05 2018VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...Option ExerciseM91.052,155196,21310,776
Nov 05 2018VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...SellS175.362,155377,90146,75248.9 K to 46.8 K (-4.41 %)
Nov 05 2018VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...BuyM91.052,155196,21348,90746.8 K to 48.9 K (+4.61 %)
Aug 06 2018VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...Option ExerciseM86.521,553134,36615,533
Aug 06 2018VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...Option ExerciseM109.144,250463,8458,500
Aug 06 2018VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...Option ExerciseM91.052,155196,21312,931
Aug 06 2018VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...Option ExerciseM131.892,125280,2668,500
Aug 06 2018VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...SellS174.205,8031,010,88346,75252.6 K to 46.8 K (-11.04 %)
Aug 06 2018VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...BuyM86.521,553134,36652,55551 K to 52.6 K (+3.04 %)
Aug 06 2018VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...BuyM109.144,250463,84551,00246.8 K to 51 K (+9.09 %)
Aug 06 2018VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...SellS174.592,155376,24146,75248.9 K to 46.8 K (-4.41 %)
Aug 06 2018VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...BuyM91.052,155196,21348,90746.8 K to 48.9 K (+4.61 %)
Aug 06 2018VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...SellS179.002,125380,37546,75248.9 K to 46.8 K (-4.35 %)
Aug 06 2018VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...BuyM131.892,125280,26648,87746.8 K to 48.9 K (+4.55 %)
Jul 17 2018VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...Option ExerciseM96.872,125205,8490
Jul 17 2018VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...Option ExerciseM131.896,375840,79910,625
Jul 17 2018VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...SellS179.852,125382,18146,75248.9 K to 46.8 K (-4.35 %)
Jul 17 2018VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...BuyM96.872,125205,84948,87746.8 K to 48.9 K (+4.55 %)
Jul 17 2018VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...SellS179.006,3751,141,12546,75253.1 K to 46.8 K (-12.00 %)
Jul 17 2018VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...BuyM131.896,375840,79953,12746.8 K to 53.1 K (+13.64 %)
Jul 03 2018VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...Option ExerciseM86.521,553134,36617,086
Jul 03 2018VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...Option ExerciseM91.052,155196,21315,086
Jul 03 2018VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...SellS169.003,708626,65246,75250.5 K to 46.8 K (-7.35 %)
Jul 03 2018VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...BuyM86.521,553134,36650,46048.9 K to 50.5 K (+3.18 %)
Jul 03 2018VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...BuyM91.052,155196,21348,90746.8 K to 48.9 K (+4.61 %)
Jun 26 2018VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...Option ExerciseM109.144,250463,84512,750
Jun 26 2018VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...SellS159.004,250675,75046,75251 K to 46.8 K (-8.33 %)
Jun 26 2018VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...BuyM109.144,250463,84551,00246.8 K to 51 K (+9.09 %)
May 16 2018VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...SellS155.7813821,49846,75246.9 K to 46.8 K (-0.29 %)
Apr 18 2018VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...Option ExerciseM96.872,125205,8492,125
Apr 18 2018VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...SellS163.012,125346,39646,75248.9 K to 46.8 K (-4.35 %)
Apr 18 2018VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...BuyM96.872,125205,84948,87746.8 K to 48.9 K (+4.55 %)
Apr 18 2018VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...Option ExerciseM96.872,125205,8492,125
Apr 18 2018VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...SellS163.012,125346,39646,75248.9 K to 46.8 K (-4.35 %)
Apr 18 2018VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...BuyM96.872,125205,84948,87746.8 K to 48.9 K (+4.55 %)
Feb 28 2018VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...Option ExerciseM86.521,554134,45218,639
Feb 28 2018VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...SellS169.006,4591,091,57146,75253.2 K to 46.8 K (-12.14 %)
Feb 28 2018VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...BuyM86.521,554134,45253,21151.7 K to 53.2 K (+3.01 %)
Feb 15 2018VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...SellS152.262,022307,87051,65753.7 K to 51.7 K (-3.77 %)
Feb 15 2018VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...SellS151.402,022306,13153,67955.7 K to 53.7 K (-3.63 %)
Feb 08 2018VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...Option ExerciseA155.5719,5663,043,88319,566
Feb 08 2018VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...GrantA0.008,437062,52554.1 K to 62.5 K (+15.60 %)
Feb 08 2018VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...GrantA0.0012,136054,08842 K to 54.1 K (+28.93 %)
Feb 07 2018VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...Option ExerciseM109.144,250463,84517,000
Feb 07 2018VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...Option ExerciseM109.144,250463,84517,000
Feb 07 2018VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...Option ExerciseM77.314,250328,5680
Feb 07 2018VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...Option ExerciseM77.314,250328,5680
Feb 07 2018VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...SellS163.088,5001,386,18041,95250.5 K to 42 K (-16.85 %)
Feb 07 2018VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...SellS163.088,5001,386,18041,95250.5 K to 42 K (-16.85 %)
Feb 07 2018VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...BuyM109.144,250463,84550,45246.2 K to 50.5 K (+9.20 %)
Feb 07 2018VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...BuyM109.144,250463,84550,45246.2 K to 50.5 K (+9.20 %)
Feb 07 2018VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...BuyM77.314,250328,56846,20242 K to 46.2 K (+10.13 %)
Feb 07 2018VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...BuyM77.314,250328,56846,20242 K to 46.2 K (+10.13 %)
Feb 05 2018VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...Option ExerciseM91.052,156196,30417,241
Feb 05 2018VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...SellS169.422,156365,27041,95244.1 K to 42 K (-4.89 %)
Feb 05 2018VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...BuyM91.052,156196,30444,10842 K to 44.1 K (+5.14 %)
Jan 26 2018VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...Option ExerciseM86.524,659403,09720,193
Jan 26 2018VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...Option ExerciseM91.054,310392,42619,397
Jan 26 2018VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...SellS169.008,9691,515,76141,95250.9 K to 42 K (-17.61 %)
Jan 26 2018VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...BuyM86.524,659403,09750,92146.3 K to 50.9 K (+10.07 %)
Jan 26 2018VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...BuyM91.054,310392,42646,26242 K to 46.3 K (+10.27 %)
Jan 17 2018VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...Option ExerciseM96.872,125205,8494,250
Jan 17 2018VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...SellS158.282,125336,34541,95244.1 K to 42 K (-4.82 %)
Jan 17 2018VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...BuyM96.872,125205,84944,07742 K to 44.1 K (+5.07 %)
Jan 12 2018VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...Option ExerciseM109.144,250463,84521,250
Jan 12 2018VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...SellS159.004,250675,75041,95246.2 K to 42 K (-9.20 %)
Jan 12 2018VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...BuyM109.144,250463,84546,20242 K to 46.2 K (+10.13 %)
Nov 17 2017VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...SellS147.2922132,55141,95242.2 K to 42 K (-0.52 %)
Nov 07 2017VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...Option ExerciseM77.314,250328,5684,250
Nov 07 2017VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...SellS148.174,250629,72341,95246.2 K to 42 K (-9.20 %)
Nov 07 2017VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...BuyM77.314,250328,56846,20242 K to 46.2 K (+10.13 %)
Oct 31 2017VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...Option ExerciseM96.872,125205,8496,375
Oct 31 2017VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...SellS149.3450074,67041,95242.5 K to 42 K (-1.18 %)
Oct 31 2017VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...SellS148.541,000148,54042,45243.5 K to 42.5 K (-2.30 %)
Oct 31 2017VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...SellS147.875,000739,35043,45248.5 K to 43.5 K (-10.32 %)
Oct 31 2017VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...SellS146.617,7831,141,06648,45256.2 K to 48.5 K (-13.84 %)
Oct 31 2017VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...SellS145.3417,5012,543,59556,23573.7 K to 56.2 K (-23.73 %)
Oct 31 2017VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...SellS144.5425,9993,757,89573,73699.7 K to 73.7 K (-26.07 %)
Oct 31 2017VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...SellS143.545,600803,82499,735105.3 K to 99.7 K (-5.32 %)
Oct 31 2017VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...SellS142.1811,6171,651,705105,335117 K to 105.3 K (-9.93 %)
Oct 31 2017VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...SellS149.002,125316,625116,952119.1 K to 117 K (-1.78 %)
Oct 31 2017VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...BuyM96.872,125205,849119,077117 K to 119.1 K (+1.82 %)
Oct 31 2017VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...SellS141.414,165588,973116,952121.1 K to 117 K (-3.44 %)
Aug 09 2017VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...Option ExerciseM77.314,250328,5688,500
Aug 09 2017VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...SellS152.884,250649,740121,117125.4 K to 121.1 K (-3.39 %)
Aug 09 2017VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...BuyM77.314,250328,568125,367121.1 K to 125.4 K (+3.51 %)
Aug 04 2017VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...Option ExerciseM109.144,250463,84525,500
Aug 04 2017VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...SellS155.724,250661,810121,117125.4 K to 121.1 K (-3.39 %)
Aug 04 2017VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...BuyM109.144,250463,845125,367121.1 K to 125.4 K (+3.51 %)
Aug 02 2017VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...Option ExerciseM83.362,125177,1400
Aug 02 2017VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...SellS152.992,125325,104121,117123.2 K to 121.1 K (-1.72 %)
Aug 02 2017VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...BuyM83.362,125177,140123,242121.1 K to 123.2 K (+1.75 %)
Jul 21 2017VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...Option ExerciseM131.892,125280,26617,000
Jul 21 2017VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...Option ExerciseM91.0510,775981,06423,707
Jul 21 2017VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...Option ExerciseM131.8914,8751,961,86419,125
Jul 21 2017VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...Option ExerciseM109.1438,2504,174,60538,250
Jul 21 2017VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...Option ExerciseM96.8725,5002,470,1858,500
Jul 21 2017VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...SellS161.7220032,344121,117121.3 K to 121.1 K (-0.16 %)
Jul 21 2017VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...SellS161.6810,1501,641,052121,317131.5 K to 121.3 K (-7.72 %)
Jul 21 2017VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...SellS159.002,125337,875131,467133.6 K to 131.5 K (-1.59 %)
Jul 21 2017VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...BuyM131.892,125280,266133,592131.5 K to 133.6 K (+1.62 %)
Jul 21 2017VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...SellS162.6729,0004,717,430131,467160.5 K to 131.5 K (-18.07 %)
Jul 21 2017VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...SellS161.0060,4009,724,400160,467220.9 K to 160.5 K (-27.35 %)
Jul 21 2017VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...BuyM91.0510,775981,064220,867210.1 K to 220.9 K (+5.13 %)
Jul 21 2017VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...BuyM131.8914,8751,961,864210,092195.2 K to 210.1 K (+7.62 %)
Jul 21 2017VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...BuyM109.1438,2504,174,605195,217157 K to 195.2 K (+24.37 %)
Jul 21 2017VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...BuyM96.8725,5002,470,185156,967131.5 K to 157 K (+19.40 %)
Jun 05 2017VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...Option ExerciseM83.3631,8752,657,1002,125
Jun 05 2017VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...Option ExerciseM77.3125,5001,971,40512,750
Jun 05 2017VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...Option ExerciseM53.7413,594730,5420
Jun 05 2017VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...SellS129.0257,3757,402,523131,467188.8 K to 131.5 K (-30.38 %)
Jun 05 2017VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...BuyM83.3631,8752,657,100188,842157 K to 188.8 K (+20.31 %)
Jun 05 2017VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...BuyM77.3125,5001,971,405156,967131.5 K to 157 K (+19.40 %)

Page:   < prev 1 2 3 next >

Contact us | Follow us on Twitter